Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Low-Dose Naltrexone | Methylene Blue (Pharmaceutical Grade) | |
|---|---|---|
| Category | Pharmaceuticals | Pharmaceuticals |
| Standard Dose | — | — |
| Timing | — | — |
| Cycle Duration | — | — |
| Evidence Level | Emerging | Moderate (cognitive), Strong (mitochondrial mechanism) |
Transient opioid receptor blockade that may increase endogenous endorphin signaling and modulate immune tone in off-label protocols.
Alternative electron carrier in the mitochondrial electron transport chain. Bypasses Complex I and III dysfunction by shuttling electrons directly to Complex IV (cytochrome c oxidase). Also inhibits tau aggregation, monoamine oxidase, and nitric oxide synthase. Hormetic — low doses are beneficial, high doses are toxic.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →